A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients
Clinical trial NCT05244057 · COMPLETED
Trial details
- NCT number
- NCT05244057
- Sponsor
- Shanghai HEP Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-23
- Primary completion
- 2024-06-24
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.